Essen

• FaR-RMS: An overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma Recruiting
  2024-510579-40-00 9 2020-10-07 Rhabdoyosarcoma
• FOLFOX before surgey compared to risk-adapted chemotherapy after surgery in patients with locally advanced rectal cancer and low risk for lo … Recruiting
  2024-518077-34-00 5 2020-09-30 locally advanced rectal cancer
• Midostaurin + Gemtuzumab Ozogamicin combination in first-line standard therapy for acute myeloid leukemia (MOSAIC) Recruiting
  2024-514014-13-00 9 2020-09-02 female and male adult patients with acute myeloid leukemia
• An experimental study in adults and adolescents who underwent stem cell transplantation and developed a Graft versus Host Disease after ster … Recruiting
  2023-505737-26-00 5 2020-07-22 Steroid refractory Acute Graft versus host Disease
• An international trial for children with atypical teratoid/rhabdoid tumours (ATRT) Recruiting
  2022-501456-28-00 5 2020-07-20 atypical teratoid/rhabdoid tumours (ATRT)
• A Multicenter Randomized, Controlled, Double-blinded Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune … Recruiting
  2024-514494-21-00 4 2020-05-13 autoimmune encephalitis
• Pan tumor Roll Over Study Recruiting
  2023-506914-32-00 4 2020-05-05 Pan tumor
• A PROSPECTIVE, OPEN-LABEL, MULTICENTRE PHASE-II-TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF ZANUBRUTINIB (BGB-3111), A BTK INHIBI-TOR, PLUS … Recruiting
  2023-504653-12-00 4 2020-02-10 Patients with previously untreated Richter Transformation or patients
• International study for children and adolescents with standard risk ALK-positive anaplastic large cell lymphoma (ALCL) estimating the effica … Recruiting
  2022-501454-11-00 5 2020-02-05 standard risk ALK-positive anaplastic large cell lymphoma (ALCL)
• SIOP RANDOMET 2017 Recruiting
  2023-508926-91-00 5 2019-12-05 Stage IV childhood renal tumour with pulmonary +/- non-pulmonary metas
• Randomized, double-blind, placebo-controlled, multi-centre trial to evaluate the efficacy, safety and tolerability of oral treatment with li … Recruiting
  2024-512104-19-00 6 2019-11-19 Irritable Bowel Syndrome
• Long-term efficacy, safety and tolerability of LNP023 in C3G or IC-MPGN Recruiting
  2023-509343-27-00 11 2019-10-28 C3 Glomerulopathy or idiopathic immune-complex membranoproliferative g
• Phase 2a Study of Luspatercept in Pediatric Participants With Beta (β)-Thalassemia Recruiting
  2022-502499-22-00 4 2019-10-15 Beta (β) Thalassemia
• Treatment of chemo-refractory viral infections after allogeneic stem cell transplantation with multispecific T cells against CMV, EBV and Ad … Recruiting
  2024-512321-84-00 5 2019-10-02 Patients after HSCT suffering from new or reactivated CMV or EBV or Ad
• An open-label study to assess safety and efficacy of SZC in paediatric patients with hyperkalaemia Recruiting
  2023-508455-38-00 5 2019-09-12 Hyperkalaemia
• Glioblastoma treatment with irradiation and olaptesed pegol (NOX-A12) in unmethylated patients Recruiting
  2024-510964-21-00 9 2019-09-12 Glioblastoma
• LBL 2018 - International cooperative treatment protocol for children and adolescents with lymphoblastic lymphoma Recruiting
  2023-508101-24-00 5 2019-08-01 Lymphoblastic lymphoma
• INFORM2 exploratory multinational phase I/II combination study of Nivolumab and Entinostat in children and adolescents with refractory high- … Recruiting
  2024-514409-78-01 9 2019-07-26 relapsed / refractory or progressive high risk malignant disease
• Long-Term Follow-up Protocol for Subjects Treated with Gene-Modified T cells. Recruiting
  2023-504201-36-00 10 2018-12-21 Defined by parent protocol. The study will enroll all adult and paedia
• A Study to Evaluate Efficacy and Safety of Multiple Treatment Combinations in Patients with Metastatic Breast Cancer (MORPHEUS-panBC) Recruiting
  2023-503629-20-00 9 2018-06-27 Metastatic breast cancer, including triple negative breast cancer (TNB
• A phase 1B of crizotinib either in combination or as single agent in pediatric patients with ALK, ROS1 or MET positive malignancies Recruiting
  2023-504880-18-00 9 2018-04-18 Neuroblastoma (NBL)
• Paediatric Hepatic International Tumour Trial Recruiting
  2024-516110-38-00 5 2018-03-06 Hepatoblastoma and Hepatocellular Carcinoma
• Prospective, randomized study concerning personalized medicine with Pentaglobin® after interventional infectious source control in peritonit … Recruiting
  2024-513526-27-00 4 2018-02-23 secondary or quaternary peritonitis
• Study to allow access to dabrafenib and/or trametinib for subjects that are benefiting from dabrafenib and/or trametinib treatment in a Nova … Recruiting
  2023-509318-13-00 6 2018-01-15 Multiple indications

Showing 433–456 of 965 trials